- Home
- GDOT vs ARCT Comparison
GDOT vs ARCT Comparison
Compare GDOT & ARCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GDOT
- ARCT
- Stock Information
- Founded
- GDOT 1999
- ARCT 2013
- Country
- GDOT United States
- ARCT United States
- Employees
- GDOT N/A
- ARCT N/A
- Industry
- GDOT Finance: Consumer Services
- ARCT Biotechnology: Pharmaceutical Preparations
- Sector
- GDOT Finance
- ARCT Health Care
- Exchange
- GDOT Nasdaq
- ARCT Nasdaq
- Market Cap
- GDOT 577.7M
- ARCT 602.7M
- IPO Year
- GDOT 2010
- ARCT N/A
- Fundamental
- Price
- GDOT $10.78
- ARCT $15.48
- Analyst Decision
- GDOT Hold
- ARCT Strong Buy
- Analyst Count
- GDOT 4
- ARCT 7
- Target Price
- GDOT $10.75
- ARCT $65.00
- AVG Volume (30 Days)
- GDOT 574.6K
- ARCT 412.0K
- Earning Date
- GDOT 11-07-2024
- ARCT 11-07-2024
- Dividend Yield
- GDOT N/A
- ARCT N/A
- EPS Growth
- GDOT N/A
- ARCT N/A
- EPS
- GDOT N/A
- ARCT N/A
- Revenue
- GDOT $1,629,683,000.00
- ARCT $160,399,000.00
- Revenue This Year
- GDOT N/A
- ARCT $6.91
- Revenue Next Year
- GDOT $10.91
- ARCT $5.24
- P/E Ratio
- GDOT N/A
- ARCT N/A
- Revenue Growth
- GDOT 10.45
- ARCT N/A
- 52 Week Low
- GDOT $7.70
- ARCT $14.30
- 52 Week High
- GDOT $13.58
- ARCT $45.00
- Technical
- Relative Strength Index (RSI)
- GDOT 48.01
- ARCT 38.67
- Support Level
- GDOT $10.54
- ARCT $14.30
- Resistance Level
- GDOT $11.44
- ARCT $20.92
- Average True Range (ATR)
- GDOT 0.45
- ARCT 1.27
- MACD
- GDOT 0.04
- ARCT -0.26
- Stochastic Oscillator
- GDOT 42.69
- ARCT 17.82
About GDOT Green Dot Corporation $0.001 par value
Green Dot Corp is a financial technology company that provides financial services for consumers in the United States without good banking options. It has three segments Consumer Services, Business to Business Services(B2B), and Money Movement Services. The company generates maximum revenue from B2B segment. Its B2B Services segment consists of revenues and expenses derived from (i) its partnerships with prominent consumer and technology companies that make banking products and services available to their consumers, partners and workforce through integration with its banking platform (the "Banking-as-a-Service", or "BaaS channel"), and (ii) a comprehensive payroll platform that it offers to corporate enterprises (the "Employer channel") to facilitate payments for today's workforce.
About ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in the research and development segment of medical applications for nucleic acid-focused technology. The company's product pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU and LUNAR-COV19.